We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 11

Antitrust, competition and economic regulation client quarterly newsletter

  • Hogan Lovells
  • -
  • China, European Union, Greece, USA
  • -
  • January 24 2012

A public company CEO recently consented to a federal district court order requiring him to pay a $500,000 civil penalty for violating the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”

Commission asks ECJ to fine Greece for failure to comply with its judgment on medical equipment

  • Nabarro LLP
  • -
  • European Union, Greece
  • -
  • November 29 2010

On 19 March 2009, the European Court of Justice (ECJ) ruled that Greece had breached EU law by rejecting offers from suppliers of medical equipment bearing the 'CE' mark

Preventing parallel trade in the European Union

  • McDermott Will & Emery
  • -
  • European Union, Greece
  • -
  • October 31 2008

Lelos and Others v GSK C-46806 concerned a dispute between the Greek subsidiary of GlaxoSmithKline (GSK) and a number of Greek wholesalers

ECJ rules in major pharmaceuticals case

  • Squire Sanders
  • -
  • European Union, Greece
  • -
  • October 30 2008

The European Court of Justice (ECJ) has issued a preliminary ruling in the dispute over supply quotas imposed by GlaxoSmithKline (GSK) on prescription drug wholesalers in Greece

Parallel trade in medicines: ECJ judgment in the second reference re: GlaxoSmithKline’s supply policy in Greece and abuse of dominant position

  • Bird & Bird
  • -
  • European Union, Greece
  • -
  • October 16 2008

In the second reference to the European Court of Justice arising out of GSK’s policy of selling medicines directly to Greek hospitals and pharmacies the ECJ has held (Joined Cases C-46806 to C-47806 Sot. Lelos kai Sia and Others) that an undertaking which occupies a dominant position on the relevant market for medicinal products is abusing its dominant position contrary to Article 82 EC if, in order to stop parallel exports, it refuses to meet “ordinary orders” from wholesalers

ECJ delivers long-awaited judgment in Glaxo ‘Greek’ Case on parallel imports

  • Hogan Lovells
  • -
  • European Union, Greece
  • -
  • September 22 2008

On September 16, 2008, the European Court of Justice (ECJ) handed down a long-awaited judgment in Sot Lélos kai Sia EE and Others v. GlaxoSmithKline AEVE Farmakeftikon Proïonton1 (the Greek Glaxo Case

Syfait II

  • NautaDutilh
  • -
  • European Union, Greece
  • -
  • September 17 2008

Yesterday, the EC Court of Justice (ECJ) handed down its long awaited judgment in the Syfait II Case (Joined Cases C-46806 - C-47806, Sot. Lélos kai Sia), which deals with stock management in the pharmaceutical sector

Advocate General’s opinion supporting parallel trade in Greek case against GSK

  • Bird & Bird
  • -
  • European Union, Greece
  • -
  • May 7 2008

The long running saga of disputes between Greek exporter wholesalers and GSK following GSK’s refusal of supplies for export purposes has taken a new turn

AG gives Opinion in pharmaceutical parallel trade case

  • Nabarro LLP
  • -
  • European Union, Greece
  • -
  • April 16 2008

On 1 April 2008, Advocate-General Colomer (AG) gave his Opinion, on a reference from a Greek court, on whether a refusal by a dominant pharmaceutical company to meet the full orders of wholesalers amounted to an abuse of a dominant position contrary to Article 82 of the EC Treaty

GlaxoSmithKline infringed competition rules by restricting parallel trade

  • McDermott Will & Emery
  • -
  • European Union, Greece
  • -
  • April 4 2008

Advocate General Ruiz-Jarabo has delivered a non-binding opinion to the European Court of Justice (ECJ), finding that GlaxoSmithKline Plc (GSK) abused its dominant position by limiting distribution of certain pharmaceuticals to Greek wholesalers